All official European Union website addresses are in the europa.eu domain.See all EU institutions and bodies
Coordinating and advancing human biomonitoring in Europe to provide evidence for chemical policymaking.
Aims and objectives
Human biomonitoring for Europe (HBM4EU) was a joint initiative of 28 participating countries – the 24 EU member states plus Norway, Switzerland, Iceland and Israel – and the European Environment Agency. The project received EUR 74 milion in funding under Horizon 2020 (European Commission) and was jointly implemented by 120 partners from the participating countries. Its aim was to measure Europeans’ exposure to chemicals and their health effects and develop human biomonitoring (HBM) as an exposure assessment method.
Its follow-up project “Partnership for the Assessment of Risks in Chemicals (PARC)” takes the HBM4EU work forward by strengthening the scientific basis for chemical risk assessment and facilitating the EU’s transition to next generation evidence-based risk assessment.
Grant Agreement ID
Grant Agreement No 101057014
Horizon Europe research and innovation programme
01/05/2022 - 30/04/2029
EUR 400 milion
EUR 4.24 milion